Pular para o conteúdo
Doença autoimune sistêmica
ORPHA:182228DOENÇA RARA

OBSOLETO. Uma forma autoimune de doença sistêmica.

Última verificação: Fonte: sem afirmação sobre o SUS a verificarEm construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

Mantido pelo Disease Twin100% com fonte · atualizado 23/09/2026Revisão médica pendente
Informacoes curadas por IA — podem conter imprecisoes

Visão geral

A doença autoimune sistêmica (identificador MONDO:0015939) possui registro com a descrição de termo obsoleto referente a uma forma autoimune de doença sistêmica.[1]

Tratamentos citados na literatura

Com base em mineração da literatura científica no PubTator3, foram identificadas associações com termos e compostos relacionados, não constituindo recomendação médica: Steroids (447 publicações), Rituximab (266 publicações), Prednisolone (147 publicações), Prednisone (84 publicações), Fluorodeoxyglucose F18 (65 publicações), Azathioprine (63 publicações), Cyclophosphamide (46 publicações), Mycophenolic Acid (39 publicações), 1 (5 (2 fluorophenyl) 1 (pyridin 3 ylsulfonyl) 1H pyrrol 3 yl) N methylmethanamine (29 publicações) e Methylprednisolone (27 publicações). Há também o registro de 1 ensaio clínico ativo.[2]

Fontes numeradas em Referências.

Conteúdo informativo gerado e mantido automaticamente a partir de fontes oficiais (Orphanet, HPO, OMIM, SUS). Não substitui avaliação médica.

💬
EM LINGUAGEM SIMPLES

O termo doença autoimune sistêmica é classificado como uma categoria clínica ampla e obsoleta nos catálogos internacionais. Não há uma lista de sintomas únicos ou de alterações genéticas padronizadas para essa entrada isolada. No Brasil, esta denominação não consta na lista oficial de protocolos de doenças raras do Ministério da Saúde. O acompanhamento médico e a assistência dependem da identificação da doença específica que acomete cada pessoa.

Informacoes curadas por IA — podem conter imprecisoes
[1] Orphanet [16] Ministério da Saúde — lista oficial de…
📋
Informacoes curadas por IA — podem conter imprecisoes

OBSOLETO. Uma forma autoimune de doença sistêmica.

Pesquisas ativas
1 ensaio
5 total registrados no ClinicalTrials.gov
Publicações científicas
2.782 artigos
Último publicado: 2026 Apr 13
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico2.782PubMed
Últimos 10 anos200publicações
Pico2025121 papers
Linha do tempo
2026Hoje · 2026🧪 2021Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico5
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 5 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença autoimune sistêmica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Onde estão os ensaios

Com ensaio aberto em 2 países. O ponto verde marca onde há vaga agora.

Pesquisa e ensaios clínicos

5 ensaios clínicos encontrados, 1 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
1.761 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 1.761

#1

Case Report: A classical PSGN case with unusually prominent serosal manifestations and complement patterns that mimicked systemic autoimmune disease-highlighting diagnostic pitfalls and biopsy decision-making.

Frontiers in pediatrics2026

Post-Streptococcal glomerulonephritis (PSGN) most commonly follows streptococcal infections and presents with classic features such as hematuria, proteinuria, hypertension, and transient renal dysfunction. While renal-limited disease is typical, extrarenal manifestations-particularly serosal involvement-are exceptionally rare in children. We report a rare case of an adolescent who presented with nephritic syndrome marked by hypertension, gross hematuria, proteinuria, and notably, concurrent pleural and pericardial effusions. Laboratory evaluation revealed low serum complement levels (C3 and C4), consistent with immune complex-mediated glomerulonephritis. Extensive infectious and autoimmune workups were unremarkable. The patient was managed conservatively with antihypertensives and diuretics, with complete resolution of symptoms and normalization of renal function and complement levels within four weeks. To our knowledge, serosal involvement (pleural and pericardial effusions) at initial presentation in pediatric PSGN remains extremely rare, with very few documented cases in the literature. This report contributes valuable clinical insight, emphasizing that PSGN can occasionally mimic systemic inflammatory or autoimmune conditions. Early identification and conservative management can prevent overtreatment and improve outcomes. This case underscores an unusual presentation of PSGN with serosal involvement-a manifestation reported only sporadically in literature. Recognition of such rare systemic features is crucial to avoid diagnostic delays or unnecessary immunosuppression. Supportive care alone led to favorable outcomes, reinforcing the self-limited nature of PSGN even in atypical presentations. It serves as a valuable reminder that atypical PSGN can present with multi-system inflammation, and a precise diagnostic approach integrating serology and clinical course is essential to avoid unnecessary intervention.

#2

The Oral-Gut-Immune-Nutrition Axis in Rheumatoid Arthritis: Molecular Mechanisms and Therapeutic Implications.

International journal of molecular sciences2026 Mar 04

Rheumatoid arthritis is a chronic systemic autoimmune disease that arises from complex interactions among genetic susceptibility, environmental factors, and immune dysregulation. Growing evidence indicates that microorganisms residing in the oral cavity and gastrointestinal tract, together with dietary factors, play a central role in shaping inflammatory and autoimmune responses in rheumatoid arthritis, forming an interconnected microbiome-immune-nutrition axis. Alterations in the composition and function of oral and intestinal microbial communities are associated with disruption of mucosal barrier integrity, activation of innate and adaptive immune pathways, increased differentiation of proinflammatory T lymphocyte subsets, and loss of immune tolerance that promotes autoantibody production. In addition, microbially derived metabolites, particularly short-chain fatty acids, provide a mechanistic link between microbial ecology, immune regulation, and bone metabolism. Diet represents a key upstream modulator of this axis. Dietary patterns rich in anti-inflammatory nutrients support microbial diversity and immunoregulatory metabolite production, whereas diets high in processed foods and saturated fats favor proinflammatory microbial profiles. Accumulating clinical evidence suggests that nutritional strategies and microbiome-targeted dietary interventions may reduce systemic inflammation and disease-related comorbidities when used alongside standard pharmacological treatments. Taken together, the microbiome-immune-nutrition axis represents a modifiable and clinically meaningful target in rheumatoid arthritis, emphasizing the need for interdisciplinary research and well-designed clinical trials to translate these insights into personalized approaches for disease management. The aim of this review is to integrate current mechanistic and clinical evidence on the interactions between the microbiome, immune system, and nutrition in rheumatoid arthritis, with a focus on their pathogenic relevance, therapeutic potential, and implications for personalized, diet-based interventions.

#3

A novel mRNA nanovaccine with dual immunoregulation ameliorates rheumatoid arthritis and associated pneumonia.

Asian journal of pharmaceutical sciences2026 Feb

Rheumatoid arthritis (RA) as a systemic autoimmune disease, frequently triggers various extra-articular symptoms, particularly the RA-associated pneumonia. Unfortunately, the RA-associated pneumonia has garnered insufficient attention, and conventional RA therapies may exacerbate pneumonia-related complications, thereby complicating the treatment process. Herein, a novel dual immunoregulatory mRNA nanovaccine (MPDA@RC@HM) is designed for the efficient treatment of RA and RA-associated pneumonia simultaneously. This innovative mRNA nanovaccine represents a highly organized nanostructure that integrates the rapamycin-loaded mesoporous polydopamine (MPDA) with mRNA encoding the epitope of type Ⅱ collagen, and the surface is modified with hyaluronic acid and dendritic cell membrane. After intravenous injection into collagen-induced arthritis mice, the mRNA nanovaccine exhibits effective distribution and transfection within the spleen and lung, subsequently exerting potent immunoregulation in both organs, thereby yielding a dual therapeutic effect. This study presents a versatile mRNA nanovaccine platform for the treatment of autoimmune diseases and provides an innovative approach for addressing RA and RA-associated pneumonia.

#4

Clinical utility and performance of anti-C1q antibodies for SLE: comparative analysis of three different assays.

Lupus science & medicine2026 Mar 06

Despite the reported clinical significance of anti-C1q immunoglobulin G autoantibodies (anti-C1q) for SLE and the development of anti-C1q commercial kits, their performance characteristics in routine patient evaluation remain poorly defined. In this cross-sectional study, an unselected cohort of 107 patients with suspicion of a systemic autoimmune disease and 102 controls were included and evaluated for anti-C1q autoantibodies with three kits (Bühlmann, Orgentec and Werfen). Patients in the unselected cohort were classified as having SLE or a mimicker condition. Disease activity was assessed using Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)-2K and SLE patients were subclassified based on the presence of lupus nephritis (LN) (history/active). Each kit was assessed for diagnostic performance. The degree of association between anti-C1q and SLEDAI/complement levels was assessed using the Spearman correlation coefficient (rho). Between-kit agreement was evaluated using Fleiss Ƙ. Werfen had the best performance in discriminating patients with SLE from non-SLE (area under the curve (AUC)=0.76), whereas for the SLE versus mimicker comparison Bühlmann (AUC=0.71) and Werfen (AUC=0.71) exhibited adequate discrimination. Among patients with SLE, all kits exhibited poor discrimination of patients with history of LN versus non-renal SLE, but Orgentec displayed good discrimination for patients with active LN from non-active LN (AUC=0.74). A positive correlation was observed between anti-C1q and SLEDAI scores, whereas a negative correlation was found between anti-C1q and complement C3 and C4 across all kits. Agreement for SLE between the three kits was moderate (Ƙ=0.42). Anti-C1q can identify patients with SLE and correlate with global and renal disease activity, highlighting their potential to function as follow-up markers in SLE. Agreement with commercial anti-C1q kits is variable. Further studies are required to harmonise anti-C1q kits for optimal routine patient evaluation.

#5

Spatial transcriptomics reveals mechanism of autoimmunity driven by internalized autoantibodies.

medRxiv : the preprint server for health sciences2026 Mar 05

Autoantibody internalization has been implicated in autoimmune disease pathogenesis, yet its mechanisms, and generality across different diseases, cell types, and affected tissues remain poorly defined. Using bulk RNA sequencing, we identified reproducible, autoantibody-specific transcriptomic signatures consistent with autoantigen dysfunction in muscle biopsies from patients with anti-Mi2 dermatomyositis and anti-PM/Scl scleromyositis across independent cohorts. Electroporation of purified patient IgG into primary cultures of healthy cells was sufficient to induce the corresponding transcriptomic programs in vitro. Direct immunofluorescence demonstrated immunoglobulin internalization into subcellular compartments matching the localization of the autoantigen in different affected tissues. Spatial transcriptomic analyses revealed that antibody-secreting cells translocated cytoplasmic material (i.e., immunoglobulin RNA) into adjacent affected cells expressing autoantibody-specific transcripts. The disease-specific transcripts were present not only in muscle fibers, but also in other cells, including macrophages, endothelial cells, and fibroblasts. Autoantibody-induced transcriptomic programs were associated with cell damage and autoantibody-specific reactive inflammatory programs, including activation of type I interferon and TGF-ß1 signaling in anti-Mi2 dermatomyositis and activation of type II interferon in anti-PM/Scl scleromyositis. Antibody internalization was also observed in different tissues from patients with other autoimmune diseases, including anti-U1RNP mixed connective tissue disease, anti-Ku overlap syndrome, and anti-Scl70 systemic sclerosis. Together, these findings establish autoantibody internalization as a shared pathogenic mechanism across diverse autoimmune diseases, providing a unifying framework for conditions driven by autoantibodies against intracellular antigens.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC151 artigos no totalmostrando 200

2026

Case Report: A classical PSGN case with unusually prominent serosal manifestations and complement patterns that mimicked systemic autoimmune disease-highlighting diagnostic pitfalls and biopsy decision-making.

Frontiers in pediatrics
2026

MINOCA (Myocardial Infarction With Non-obstructive Coronary Arteries) Due to Diffuse Coronary Microvascular Dysfunction in a Patient With Systemic Autoimmune Disease and Chronic Kidney Disease.

Cureus
2026

Diode-laser-assisted biopsy and photobiomodulation therapy in the management of Sjögren's disease: a case report.

Journal of medical case reports
2026

Immunopathogenesis of accelerated atherosclerosis in systemic lupus erythematosus: from innate and adaptive dysregulation to clinical implications.

Frontiers in immunology
2026

[Proposal of the rheumatology societies in the D-A-CH region for a uniform German nomenclature for Sjögren's disease].

Zeitschrift fur Rheumatologie
2026

Immune checkpoint imbalance in ANCA-associated vasculitis: insights into disease activity and precision immunotherapy.

Frontiers in medicine
2026

Increased soluble CD200 in serum of SLE patients does not reflect disease activity or affect CD200R1 function in T cells.

Arthritis research & therapy
2026

Rheumatoid Arthritis Management: Emerging Drug Therapies and Innovations.

Current drug targets
2026

The Oral-Gut-Immune-Nutrition Axis in Rheumatoid Arthritis: Molecular Mechanisms and Therapeutic Implications.

International journal of molecular sciences
2026

Clinical characteristics and cancer risk of anti-OJ antisynthetase syndrome: A cohort comparative study and a systematic literature review.

Autoimmunity reviews
2026

Lnc-CHRM4-2:1 Inhibits M2 Polarization and Efferocytosis of Macrophages by Downregulating MerTK and SLC2A1 in Rheumatoid Arthritis.

Journal of immunology research
2026

[Rheumatoid arthritis pathogenesis. From susceptibility to autoimmunity, and arthritis].

Revue medicale suisse
2026

A novel mRNA nanovaccine with dual immunoregulation ameliorates rheumatoid arthritis and associated pneumonia.

Asian journal of pharmaceutical sciences
2026

Multi-Technology Empowers Dissolving Microneedles: A Novel Strategy in Rheumatoid Arthritis.

Drug design, development and therapy
2026

Unraveling the role of human endogenous retroviruses in rheumatoid arthritis.

Autoimmunity reviews
2026

Establishment of a mouse model of propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.

Animal models and experimental medicine
2026

Blood-based epigenetic biomarkers in rheumatoid arthritis: current knowledge and future perspectives.

Frontiers in immunology
2026

From Hemolysis to Lupus: A Case of Evans Syndrome Revealing Systemic Autoimmunity.

Clinical case reports
2026

Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome.

European journal of obstetrics, gynecology, and reproductive biology
2026

Association Between Rheumatoid Arthritis and Gastrointestinal Comorbidities: Evidence From Taiwan's National Health Insurance Database.

International journal of rheumatic diseases
2026

Modern Research on Traditional Chinese Ethnomedicines for Rheumatoid Arthritis: Acting Through Signaling Pathways.

Phytotherapy research : PTR
2026

Clinical utility and performance of anti-C1q antibodies for SLE: comparative analysis of three different assays.

Lupus science & medicine
2026

[Epidemiology and manifestations of Sjögren's disease].

Zeitschrift fur Rheumatologie
2026

Granulomatosis with polyangiitis. A diagnostic challenge in pediatric patients.

Archivos de la Sociedad Espanola de Oftalmologia
2025

Association of body mass index with the risk of rheumatoid arthritis: a systematic review and meta-analysis.

Frontiers in medicine
2026

Central Diabetes Insipidus as a Rare Cause of Polyuria.

Annals of African medicine
2026

Neuropsychiatric Systemic Lupus Erythematosus Diagnosed Following Treatment Initiated for Acute Encephalitis.

Cureus
2026

Spatial transcriptomics reveals mechanism of autoimmunity driven by internalized autoantibodies.

medRxiv : the preprint server for health sciences
2026

Activity and Damage Indices for Sjögren's Disease.

Journal of clinical medicine
2026

Association of Vitamin D Deficiency with Mortality and Cardiorenal Events in Sjögren's Syndrome and Osteoporosis.

Journal of clinical medicine
2026

Factors Associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA): Real-World Evidence from a Single-Center Cross-Sectional Study.

Journal of personalized medicine
2026

Pauci-Immune Crescentic Glomerulonephritis Associated With Primary Sjögren Syndrome: A Case Report.

Cureus
2026

Peripheral ulcerative keratitis (PUK) in autoimmune diseases: a severe ocular manifestation not always associated with systemic disease activity.

European journal of internal medicine
2026

Respiratory complications of systemic autoimmune diseases: the emerging and important role of palliative care.

Current opinion in supportive and palliative care
2026

Cardiovascular Disease and Risk Factors among Patients with Rheumatoid Arthritis in a Tertiary Government Hospital in the Philippines.

Acta medica Philippina
2026

Reduced retinal microvascular density in patients with mixed connective tissue disease: an exploratory pilot study on the interplay between aging, renal function, and complement system.

Frontiers in immunology
2026

New insights into clinical spectrum of antineutrophil cytoplasmic autoantibody associated disease.

Current opinion in nephrology and hypertension
2026

Dental infection is associated with early relapse in patients with ANCA-associated vasculitis.

RMD open
2026

T cells in Sjögren's disease: update on their role in salivary gland pathogenesis and treatment.

Current opinion in immunology
2026

Pulmonary Complications of Rheumatoid Arthritis Presenting as Spontaneous Pneumothorax and Empyema: A Case Report.

Cureus
2026

Association between sex-hormone binding globulin and cardiovascular events in patients with rheumatoid arthritis.

Clinical rheumatology
2026

FASN-mediated metabolic reprogramming drives CD4+ T cell hyperactivation in Sjögren's syndrome via fatty acid oxidation-dependent oxidative phosphorylation.

Arthritis research & therapy
2026

Lymph nodes-targeted nano-prodrug for precise B cell immunoregulation to prevent collagen-induced arthritis.

Biomaterials
2026

Skin Microbiome Profiling in Patients with Primary Sjögren Disease Compared to Healthy Individuals.

Journal of microbiology and biotechnology
2026

From Breast Mass to Paralysis: Lymphocytic Mastitis as the Sentinel Manifestation of Sjögren's Syndrome.

European journal of case reports in internal medicine
2026

Analysis of the Dynamics of Clinical Parameters and Serum Angiogenic Factors in Systemic Sclerosis Patients Undergoing Tocilizumab Treatment.

Experimental dermatology
2026

Galectin-9 potentiates salivary gland damage by inducing ferroptosis in Sjogren's disease.

Journal of molecular medicine (Berlin, Germany)
2026

Alternative splicing signatures correlate with disease severity and clinical subtypes in primary Sjögren's syndrome.

Genomics
2026

Hypoxia and oxidative stress related to inflammation and vascular aspects of the pathogenesis of psoriasis.

Skin health and disease
2026

Insights into pediatric epilepsy and systemic autoimmune disorders: A study using the national inpatient database.

Paediatrics & child health
2026

Nanomaterial-enabled rheumatoid arthritis treatment: An advanced investigation into photonic - acoustic - gaseous multimodal therapy.

Materials today. Bio
2026

Patients' perspectives of living with Sjögren disease: A systematic review of qualitative studies from the OMERACT Sjögren disease working group.

Seminars in arthritis and rheumatism
2025

Anti-NMDA receptor encephalitis unmasking Sjögren's disease: a case report and literature review.

Frontiers in immunology
2026

[Research progress on risk factors and risk prediction of cardiovascular diseases related to antiphospholipid syndrome].

Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
2026

A Narrative Review of Salivary Gland Extracellular Matrix and Sjögren's Syndrome: Research Status and Future Prospects.

Biomolecules
2026

Renal potassium wasting from hydroxychloroquine at therapeutic doses: a case report.

BMC nephrology
2026

The Effect of Comorbid Sjogren Syndrome Diagnosis on the Clinical Phenotype of Chronic Rhinosinusitis.

International archives of allergy and immunology
2026

Oral administration of probiotic colony-like micro-nano system for immunoregulation of rheumatoid arthritis.

Acta pharmaceutica Sinica. B
2025

Aberrant B cell responses as drivers of autoantibody generation and epitope diversification in SLE pathogenesis.

Frontiers in immunology
2025

Acute Hypoxemic Respiratory Failure Caused by Nonspecific Interstitial Pneumonia in Mixed Connective Tissue Disease: A Case Report.

Cureus
2026

Connecting sugar and fibrosis: Diabetes as a hidden player in rheumatoid arthritis-associated interstitial lung disease.

World journal of clinical cases
2025

Efficacy and safety of efgartigimod PH20 SC for Sjögren's disease-associated dryness: study protocol for an investigator-initiated, multicenter, phase 2, randomized, double-blind, placebo-controlled trial (OASIS study).

Frontiers in medicine
2026

Machine learning guided structural dynamics identifies translation elongation factor 1 (EEF1A1) as an immunological biomarker and marine natural products as therapeutic leads for rheumatoid arthritis with major depressive disorder.

Computers in biology and medicine
2026

Assessment of Temporomandibular Joint Degeneration in Rheumatoid Arthritis Patients Using Cone-Beam Computed Tomography and Musculoskeletal Ultrasound.

Journal of orthopaedic case reports
2025

Searching for biological processes as targets for rheumatoid arthritis targeted therapy with ANDSystem, an integrated software and information platform.

Vavilovskii zhurnal genetiki i selektsii
2026

In-silico design of a therapeutic multi-epitope peptide candidate vaccine against rheumatoid arthritis.

Human immunology
2026

Association of lipid-based insulin resistance indices with rheumatoid arthritis prevalence: a cross-sectional study from NHANES 2007-2018.

Clinical rheumatology
2026

Spotlight on Sjögren's: a patient perspective on burden of illness and unmet needs - results from a real-world survey.

RMD open
2025

Childhood Sjögren's Disease: A Literature Review of an Underrecognized Autoimmune Entity in Pediatric Rheumatology.

Cureus
2026

Lipid droplet-targeted and ratiometric fluorescent probe for imaging ClO- in Rheumatoid arthritis model.

Analytica chimica acta
2026

Choroidal vitiligo: systematic review of imaging findings, clinical presentation, and diagnostic considerations.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2025

Lipoprotein(a) at the crossroads of inflammation and atherosclerosis in rheumatoid arthritis: A narrative review.

Journal of clinical lipidology
2026

Sjögren's disease metabolome reveals biomarker signatures to characterise patients and assess disease activity.

RMD open
2025

Primary Sjögren's Syndrome Presenting With Hypokalemic Rhabdomyolysis, Distal Renal Tubular Acidosis, and Fulminant Necrotizing Vasculitis: A Case Report.

Cureus
2025

Case Report: The case of atypical OAPS complicated by positive anti-SSA and anti-SSB antibodies.

Frontiers in immunology
2025

Hepatic Haemangioma Mimicking an Abscess in a Young Female: An Atypical Presentation of SLE.

Cureus
2026

IL-36 mediates immune activation in Sjögren's disease and may represent a novel biomarker of disease.

Journal of leukocyte biology
2026

Serum Metrnl as a potential biomarker for renal involvement in ANCA-associated vasculitis.

Clinical and experimental immunology
2025

Effectiveness and safety of tocilizumab in refractory noninfectious uveitis: a systematic review and meta-analysis.

Frontiers in pharmacology
2025

Weighing Dose-Related Benefits and Risks of Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus.

Arthritis & rheumatology (Hoboken, N.J.)
2025

Sjögren's Hands-On Practice Exchange (SHAPE): a qualitative, expert opinion project in Sjögren's disease clinical practice.

BMC rheumatology
2026

Managing cardiovascular risk factors in patients with Sjögren's disease: a comprehensive approach.

Future cardiology
2025

Sex disparities in the phenotype at diagnosis of Sjögren's disease: artificial intelligence-driven characterisation in 17,416 patients.

Clinical and experimental rheumatology
2026

Current and future treatment of rheumatoid arthritis.

Journal of rheumatic diseases
2025

Long-term outcomes of mitral valve replacement in patients with systemic autoimmune disease: a nationwide retrospective cohort study.

International journal of surgery (London, England)
2025

Cardiac blocks in acute rheumatic fever: from complete AV block to sinus rhythm.

Cardiology in the young
2025

[Change from Sjögren syndrome to Sjögren disease].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
2025

Exploring Levator Palpebrae Superioris Myositis: A Rare Cause of Ptosis.

Cureus
2026

Sphinganine as a potentially relevant metabolite in pulmonary involvement of primary Sjögren's syndrome.

Journal of lipid research
2025

Development of mesenchymal stem cells: therapeutic effect and prospect for rheumatoid arthritis.

Stem cell research & therapy
2025

A Case of Isolated Autoimmune Ureteritis in A 25-Year-Old Male.

European journal of case reports in internal medicine
2025

Novel Sequential Therapy with Obinutuzumab and Telitacicept in Severe Lupus Nephritis with Glucocorticoid-Induced Avascular Necrosis (AVN) of the Femoral Head: A Case Report.

The American journal of case reports
2025

Lactobacillus helveticus Alleviates Collagen-Induced Arthritis in Rats Through Inflammation Modulation and Gut Microbiota Regulation.

Nutrients
2025

Eosinophilic Fasciitis in a Young Adult: A Rare Presentation Potentially Triggered by the Epstein-Barr Virus.

Cureus
2025

An Unusual Presentation of Antiphospholipid Syndrome With Seizures and Sagittal Sinus Thrombosis: A Case Report.

Cureus
2026

Single-cell RNA sequencing and proteomics uncover glycolytic dysregulation linking skin and systemic inflammation in dermatomyositis.

The British journal of dermatology
2026

Total flavonoids of Drynaria fortunei ameliorates rheumatoid arthritis by suppressing P. copri-mediated Th17 cell differentiation.

Journal of ethnopharmacology
2025

A multi-criterion feature integration framework for accurate diagnosis of Sjögren's disease using routine laboratory tests.

NPJ digital medicine
2025

Acute Spinal Epidural Hematoma: A Serious Complication of Chiropractic Therapy-A Case Report.

Journal of emergency nursing
2025

Longitudinal impact of sarcopenia and its components on falls, fractures, and mortality in rheumatoid arthritis: a six-year study.

BMC rheumatology
2025

The sex-biased chromatin modifier SMC1A promotes autoimmunity by shaping inflammatory pathways in patients with SLE.

Nature communications
2025

Warm Autoimmune Hemolytic Anemia Unmasked by Blood Transfusion in a Patient With Prostate Cancer: A Case Report.

Cureus
2025

Clinical Spectrum and One-Year Outcomes of Central Nervous System Vasculitis Secondary to Systemic Autoimmune Disorders: A Retrospective Cohort Study.

Cureus
2025

Single mutation tunes IRF4 function and mediates B cell character to ameliorate murine lupus.

iScience
2025

Anti-CD206 CAR T Cell Treatment Restores Fibrosis-Induced Loss of Dermal White Adipose Tissue.

bioRxiv : the preprint server for biology
2026

Macrophage Cell Culture and Characterization by Serum Human AB in Health and Disease.

Methods in molecular biology (Clifton, N.J.)
2025

LGI1 Antibody-Associated Encephalitis Complicated with Sjögren's Syndrome and Acute Cerebral Infarction: A Case Report and Literature Review.

Endocrine, metabolic & immune disorders drug targets
2026

Regulated cell death in systemic lupus erythematosus: Key pathways and targeted therapies.

Autoimmunity reviews
2025

Plasma proteins and rheumatoid arthritis: A Mendelian randomization analysis.

Medicine
2025

Referral criteria from primary care to rheumatology: A qualitative study.

Reumatologia clinica
2025

Distinct Effects of Complement C4A and C4B Copy Numbers in Systemic Sclerosis Serological and Clinical Subtypes.

Arthritis & rheumatology (Hoboken, N.J.)
2025

Tofacitinib Improves Motor Symptoms in Parkinsonism Associated with a Heterozygous NGLY1 Variant and Autoimmune Disease.

European journal of case reports in internal medicine
2025

Sudden Bilateral Vision Loss in A Young Patient with Systemic Autoimmune Disease and A Normal Brain MRI, which Responded to Steroid Treatment.

European journal of case reports in internal medicine
2025

Evolution in the Diagnosis and Treatment of Myocarditis in Recent Years: State of the Art.

Journal of clinical medicine
2025

Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus.

Science translational medicine
2026

The power of genetics in decoding Sjögren's disease: current status and future development.

Current opinion in immunology
2025

Systemic sclerosis: pathogenic mechanisms and their implications for treatment.

Seminars in immunopathology
2025

The role of NFKB1 and NFKBIA in immunoglobulin A vasculitis.

Frontiers in immunology
2025

Proteins upregulated in thrombotic antiphospholipid syndrome linked to platelet function in contrast with non-antiphospholipid-related thrombosis: insights from two systematic reviews.

Lupus science & medicine
2025

The effect of baricitinib on pSTAT3 levels in IL-6- or IL-15-stimulated PBMCs isolated from patients with SLE.

Frontiers in immunology
2025

Plant-derived Bioactive Substances with Anti-rheumatoid Arthritis Properties.

Planta medica
2025

Environmental Factors Associated With Celiac Disease in Children in Southeast Iran: A Case-Control Study.

International journal of pediatrics
2025

Fever and rhabdomyolysis in a recent traveler: A case report of an uncommon presentation of anti-synthetase syndrome.

SAGE open medical case reports
2026

Mendelian Randomization Analysis of the Causal Link Between Rheumatoid Arthritis and Interstitial Lung Disease.

Respirology (Carlton, Vic.)
2025

Increased Susceptibility to Salmonella Infection in Systemic Lupus Erythematosus Compared with Other Systemic Autoimmune Diseases: Insights from a Retrospective Cohort Study from the Largest Health Care System in Taiwan.

Life (Basel, Switzerland)
2025

Temporomandibular Disorders in Patients with Rheumatoid Arthritis.

Journal of clinical medicine
2025

[KDIGO-Update: Treatment of ANCA vasculitis].

Deutsche medizinische Wochenschrift (1946)
2025

Integrated study of DNA methylation and transcriptome: a new perspective for exploring the pathogenesis of Sjögren's syndrome.

Epigenetics & chromatin
2025

Long-Standing Rheumatoid Arthritis With Elevated Epstein-Barr Virus IgG Titers: A Case Report From India.

Cureus
2025

The "sandwich" procedure for paracentral rheumatoid corneal perforation: a case report with 6-year follow-up and literature review.

Frontiers in medicine
2026

Identification of a distinctive gene signature associated with disease activity in granulomatous myositis.

Rheumatology (Oxford, England)
2025

Assessment of cardiac function and left ventricular dyssynchrony in patients with ANCA-associated vasculitis using speckle-tracking echocardiography.

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology
2025

A Case of Ruptured Posterior Inferior Cerebellar Artery Aneurysm Suggestive of Dissection in an Octogenarian Patient with Anti-Neutrophil Cytoplasmic Antibody-Related Vasculitis.

NMC case report journal
2025

Clinical Presentation and Long-Term Outcomes of Lupus Nephritis in Palestine: A Multicenter Retrospective Study.

Cureus
2025

Role of Growth Factors in the Pathogenesis of Systemic-Sclerosis-Associated Fibrosis.

International journal of molecular sciences
2025

Evaluation of Salivary HLA-DR4 and MMP-8 Levels Along with Porphyromonas gingivalis in Periodontitis Patients with Rheumatoid Arthritis.

F1000Research
2025

Potential mechanisms of acupuncture treatment for rheumatoid arthritis: a study based on network topology and machine learning.

Chinese medicine
2025

Metabolomic profiling of patients with lupus nephritis reveals unique metabolites that are modulated through type I interferon inhibition by anifrolumab treatment in a phase 2 trial.

RMD open
2025

Bioinspired catalytic nanogel as an inflammatory cascade-targeted therapeutic for rheumatoid arthritis.

Journal of nanobiotechnology
2025

Brain MRI Revealing the Probable Pathophysiology of Neuropsychiatric Lupus: A Case Report.

Cureus
2026

Granulomatosis With Polyangiitis Presenting as Acute Bilateral Facial Nerve Paralysis.

The Annals of otology, rhinology, and laryngology
2025

The Glycolysis-HIF-1α axis induces IL-1β of macrophages in rheumatoid arthritis.

Arthritis research & therapy
2025

Pathogenic Role of Cytokines in Rheumatoid Arthritis.

Journal of clinical medicine
2025

Pleural effusion as a rare manifestation of Sjögren's disease.

BMJ case reports
2025

Drivers of hospital costs in ANCA-associated vasculitis patients with long-term follow-up-a real-world cost analysis.

Clinical kidney journal
2025

Raynaud's Phenomenon, Anticentromere Antibodies and Digital Necrosis (RACAND) Is a Distinct Clinical Syndrome From Systemic Sclerosis: A Case Report and Literature Review.

Cureus
2025

The double-edged sword role of copper in rheumatoid arthritis: Mechanisms, therapeutics, and challenges.

Journal of autoimmunity
2026

Myositis-specific autoantibodies recognising Mi2 also target the AIRE protein at a shared PHD zinc finger.

Annals of the rheumatic diseases
2025

Cavitating Mesenteric Lymph Node Syndrome With Autoimmune Pancreatitis and Hepatitis: A Case Report and Literature Review.

Cureus
2025

Pearls & Oy-sters: Adult-Onset Coats Plus: A Case of Leukoencephalopathy With Calcifications, a Tumefactive Brain Lesion, and a Presumed Autoimmune Disease.

Neurology
2025

Characteristics of Late-Onset Systemic Lupus Erythematosus: Clinical Manifestations and Diagnostic and Treatment Challenges.

Drugs & aging
2025

Beyond Joints: Neuropsychiatric Benefits of TNF-α and IL-6 Inhibitors in Rheumatoid Arthritis-Narrative Review.

International journal of molecular sciences
2025

Combining computational target prioritization and a B cell maturation assay for target evaluation studies in systemic lupus erythematosus.

Translational research : the journal of laboratory and clinical medicine
2025

New Cyclic Lipopeptide Compounds for Efficiently Inhibiting Cellular Inflammation and Collagen-Induced Arthritis in Mice.

Journal of medicinal chemistry
2025

A Case of Relapsing Polychondritis with Multisystemic Involvement.

Clinical, cosmetic and investigational dermatology
2025

Research progress on the effects and mechanisms of different cell types on osteoclast differentiation in bone metabolism in rheumatoid arthritis.

Frontiers in medicine
2025

MRI-Negative Transverse Myelitis Revealing Seropositive Rheumatoid Arthritis in a Young Woman.

Cureus
2025

Exploring the alleviating effect and mechanism of the diterpenoid alkaloid Polyschistine D on rheumatoid arthritis based on network pharmacology and non-targeted metabolomics.

International immunopharmacology
2025

Case Report: Dual immunomodulatory and hematologic benefits of rituximab in refractory anemia of ANCA-associated vasculitis.

Frontiers in immunology
2025

Management of Rheumatoid Arthritis in a Patient with Aplastic Anemia and Ulcerative Colitis: A Case Report.

The American journal of case reports
2025

MiRNA-186 as a Biomarker of Disease Exacerbation in Rheumatoid Arthritis: Insights from Clinical Data and Molecular Marker Analysis.

International journal of molecular sciences
2025

Exploring the Patient Experience in Behçet's Syndrome: A Two-Phase Qualitative Study Using a Biographical-Narrative Approach.

Cureus
2025

Immunomodulatory role of natural products in treating rheumatoid arthritis.

International immunopharmacology
2025

Carrier-free Nano-Tetrandrine (PURE-T) for Psoriasis Treatment: Significant Therapeutic Efficacy and Its Regulatory Mechanism on Stratum Corneum Inflammation.

ACS applied materials & interfaces
2025

Ocular Surface Granuloma Faciale: A Clinicopathologic Study of Two Novel Conjunctival Cases with a Review of the Literature Regarding Ophthalmic Involvement.

Ophthalmic plastic and reconstructive surgery
2025

[Not just frailty-Sjögren's syndrome and polymyositis with mitochondrial pathology].

Zeitschrift fur Rheumatologie
2025

Unraveling the molecular landscape of Erdheim-Chester disease: new insights from methylome and transcriptome integration.

Leukemia
2025

Gut microbiota in rheumatoid arthritis: Mechanistic insights, clinical biomarkers, and translational perspectives.

Autoimmunity reviews
2025

Identification of circRNA expression signatures correlated with disease severity in pediatric systemic lupus erythematosus.

Frontiers in immunology
2025

B cell-targeted therapies in autoimmune skin disease: current advances and challenges.

Current opinion in immunology
2025

Anti-Mi2 autoantibodies target PHD fingers of SP140L and TIF1γ, while anti-TIF1γ autoantibodies primarily bind TIF1γ outside the PHD region.

Rheumatology (Oxford, England)
2025

Prevalence and functional characterization of anti-interferon autoantibodies in inflammatory myopathies.

Rheumatology (Oxford, England)
2025

Spleen Tyrosine Kinase Exacerbates Anti-Citrullinated Protein/Peptide Antibody-Mediated Osteoclast Bone Resorption via Promotion of Vav3 Phosphorylation.

Cell biology international
2025

Rare head and neck myositis with reversible myelodysplastic syndrome: The first reported lupus manifestation as an initial symptom.

Qatar medical journal
2025

Thyroid Status in Rheumatoid Arthritis.

Cureus
2025

Autofluorescence as a tool to detect oral lesions from systemic lupus erythematosus: a case report.

Photodiagnosis and photodynamic therapy
2025

CRISPR-Cas9 editing of TNFAIP3 variants in salivary gland epithelial cells to study Sjögren's disease pathogenesis.

Frontiers in genome editing
2025

Major cardiovascular events associated factors in a cohort of patients with rheumatoid arthritis.

Reumatologia clinica
2025

Autoimmune inner ear disease and localized scleroderma in childhood: A case report.

Reumatologia clinica
2025

Classic lipid profile and lipoprotein(a) in systemic sclerosis: a systematic review and meta-analysis of case-control studies.

Rheumatology international
2025

Calcinosis Universalis: An Atypical Presentation of Mi-2 Positive Juvenile Dermatomyositis - A Case-Based Review.

Mediterranean journal of rheumatology
2025

Management of Anticoagulation in Antiphospholipid Syndrome and Systemic Lupus Erythematosus With Concurrent Thrombosis and Hemorrhage.

Cureus
2025

Psoriasis-associated lung disease: A comprehensive review and case series.

Respiratory medicine
2025

Identifying plasma proteins and immunocyte phenotypes as risk factors in rheumatoid arthritis: The role of EPHA3 and CD28+ CD45RA+ CD8br treg cells.

Clinical rheumatology
2025

Beyond the Flare: A Case of Systemic Lupus Erythematosus Complicated by Hemophagocytic Lymphohistiocytosis.

Cureus
2025

Tlr9 expression protects against Tlr7-dependent exocrine gland and systemic disease manifestations in primary Sjögren's disease in a sex-biased manner.

Journal of autoimmunity
2025

Bibliometric and visualized analysis of the relationship between rheumatoid arthritis and periodontitis-related bacteria using CiteSpace software.

Frontiers in microbiology
2025

Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcome.

Lupus science & medicine
2025

The Therapeutic Potential of Phytochemicals Unlocks New Avenues in the Management of Rheumatoid Arthritis.

International journal of molecular sciences
2025

Evaluating the usefulness of C5 and C5AR1 as genetic biomarkers of IgA-mediated vasculitis.

Molecular medicine (Cambridge, Mass.)
2025

A Case Report of Rheumatoid Arthritis With a Migratory Pattern.

Cureus
2025

Spectral cytometry of rheumatoid arthritis patients implicates myeloid dendritic cells and granular HLA-DR+CD15+CD16+ cells in pro-inflammatory antigen presentation.

Frontiers in immunology
2025

Dermatomyositis: A Narrative Review of Skin as a Window to Muscle and Malignancy.

Cureus
2025

Homocysteine and risk of interstitial lung disease: A mendelian randomization approach to causal inference.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
2025

Nailfold videocapillaroscopy in juvenile dermatomyositis: detailed correlations between microvascular abnormalities with clinical and laboratory parameters from an observational retrospective single-center study.

Clinical rheumatology
2025

Progressive Cranial Nerve Deficits in Granulomatosis With Polyangiitis: A Case Report.

Cureus
2025

Clinical Implications of Antinuclear Antibody (ANA) and Anti-Ro/Anti-La Antibody Profile in Patients with Primary Sjögren's Syndrome: A Multicenter Cross-Sectional Study of a National Egyptian Cohort.

Open access rheumatology : research and reviews
2025

Comparison of four methods of detection of anti-double-stranded DNA in SLE patients.

The Egyptian journal of immunology
2025

Review of research on pulmonary cysts in sjögren's syndrome.

Journal of cardiothoracic surgery
2025

A Rare Case of Fulminant Myocarditis Leading to the Diagnosis of Systemic Lupus Erythematosus.

JACC. Case reports

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença autoimune sistêmica.

É de uma associação que acompanha esta doença? Fale com a gente →

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

O termo é classificado como uma categoria clínica ampla de doença sistêmica autoimune no catálogo Orphanet. Nos registros oficiais atuais, a entrada consta com status obsoleto.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

4 fontes citadas no texto · 10 publicações do grafo RarasNet (PubMed) · 3 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. MONDO
    purl.obolibrary.org
  2. Q2208472
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (2026). Doença autoimune sistêmica. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/doenca-autoimune-sistemica

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Doença autoimune sistêmica

ORPHA:182228 · MONDO:0015939
Ensaios
1 ativos
MedGen
UMLS
C2895206
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Dado público estruturado
fonte: Wikidata
Rara